Since EGF-receptor stimulates proliferation via MAP-kinases (Figure 6A), which has been established as therapeutic target in the treatment of advanced CRC, we investigated the protein expression and activation patterns of EGFR and downstream activated kinases AKT and p42/44 MAPK. This evidence concerns the gene EGFR and colorectal carcinoma.